Collection 

Clinical research in neurological disorders

Submission status
Open
Submission deadline

Our knowledge of the pathological mechanisms driving neurodegeneration in disorders like Alzheimer’s disease and Parkinson’s disease is ever increasing. However, advances in diagnostics and disease modifying therapeutics are lagging.  

The editors at Nature Communications, Communications Medicine, npj Parkinson’s Disease and Scientific Reports invite original research articles on the clinical aspects of neurological disorders and neurodegenerative diseases. This call for papers includes topics such as: biomarker discovery; approaches for more accurate diagnostics; assessment of clinical heterogeneity and in more diverse cohorts; clinical trials, both observational and interventional, as well as case studies. Preclinical work would not be within scope for this collection. 

This is a joint Collection across Nature Communications, Communications Medicine, npj Parkinson’s Disease and Scientific Reports. Please see the relevant journal webpages to check which article types the journals consider. Please note, Nature Communications and Scientific Reports will only consider original research articles, npj Parkinson’s Disease welcomes original articles, reviews, perspectives and comments with a Parkinson’s disease focus, and Communications Medicine welcomes original articles, reviews, perspectives and comments across the whole scope of the collection.

 

To submit, see the participating journals
Neurodegenerative disease concept illustration with neural networks.

Editors

Nature Communications is edited by in-house professional editors.

Communications Medicine is edited by both in-house professional editors and editorial board members.

npj Parkinson’s Disease is managed by in-house professional editors and edited by a team of external academic editors.

Scientific Reports is managed by in-house professional editors and edited by a team of editorial board members.
Our editors work closely together to ensure the quality of our published papers and consistency in author experience.
 

Hideki Mochizuki is a Professor and Chair of the Department of Neurology at Osaka University in Osaka, Japan. Professor Mochizuki’s research interest is Parkinson’s disease with a focus on its pathogenesis using neurochemical, molecular, and cell biologic studies as well as novel therapeutic approaches using gene therapy. Professor Mochizuki has been an Editorial Board Member for Scientific Reports since 2016.

 

 

Antonio Suppa is an Associate Professor of Neurology at the Department of Human Neurosciences, Sapienza University of Rome, Italy. His research activity mainly focuses on the pathophysiology of motor symptoms in Parkinson's disease and other movement disorders. For this purpose, He applies advanced non-invasive brain stimulation (NIBS) techniques for assessing synaptic plasticity in the primary motor cortex in humans. He also uses wearable technology and artificial intelligence to recognize and analyse specific motor symptoms in Parkinson's disease. Professor Suppa has been an Editorial Board Member for Scientific Reports since 2021.